Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01549600 · ClinicalTrials.gov registry record · NA
Comparison of Psyllium and Microcrystalline Cellulose on Glycemic Measures in Subjects With Impaired Fasting Glucose
A NA study of Impaired Fasting Glucose, sponsored by Procter and Gamble.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
- 1
- Study location
NCT01549600 is a NA study of Impaired Fasting Glucose that has completed, run by Procter and Gamble. The registered enrollment target is 18 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01549600, a NA study of Impaired Fasting Glucose, has completed, sponsored by Procter and Gamble.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
- 1
- Study location
Study Summary
The Purpose of this study is to compare the effects of 2 types of dietary fiber, psyllium and microcrystalline cellulose (MCC), on glycemic measures in subjects with impaired fasting glucose.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Microcrystalline Cellulose
- DIETARY_SUPPLEMENT psyllium
Study Locations (1)
North Carolina
- Duke University Medical Center - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2012-02 |
| Est. Completion | 2013-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01549600
The ClinicalTrials.gov registry entry for NCT01549600 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Procter and Gamble, which has 70 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Impaired Fasting Glucose appearing as the primary indexed condition, and to 2 interventions - of which Microcrystalline Cellulose is the first listed.
NCT01549600 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT01549600 about?
NCT01549600 is a clinical study titled "Comparison of Psyllium and Microcrystalline Cellulose on Glycemic Measures in Subjects With Impaired Fasting Glucose". The Purpose of this study is to compare the effects of 2 types of dietary fiber, psyllium and microcrystalline cellulose (MCC), on glycemic measures in subjects with impaired fasting glucose.
What is the current status of trial NCT01549600?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2012-02. Estimated completion is 2013-05.
What conditions does trial NCT01549600 study?
This clinical trial studies the following conditions: Impaired Fasting Glucose.
What interventions are being tested in trial NCT01549600?
The interventions under investigation include: Microcrystalline Cellulose (DIETARY_SUPPLEMENT), psyllium (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01549600?
This trial is sponsored by Procter and Gamble, which has 70 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01549600 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Impaired Fasting Glucose
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.